Mark Belsey, a seasoned equity research analyst with 8 years of experience, has specialized in large-cap and specialty pharma. He has an additional 6 years of pharma/medtech industry experience in market analysis, health economics/market access, and R&D drug discovery. He holds a PhD in pharmacology and an MSc in health economics and healthcare systems. Mark currently serves as the Co-Head of European Pharma Equity Research at Kepler Cheuvreux, having previously held positions at Ubs, Boston Scientific, Westlb, Fivet Capital, and Datamonitor. Mark's interests lie in healthcare investing, particularly in the pharma industry.